healthUpdated: Jul 23, 2020 21:04 ISTA new approach from Tel Aviv University can save the lives of cancer patients! According to the University researchers, patients require immunotherapeutic treatment as well as treatment to reduce inflammation and physical and psychological stress. Immunotherapeutic treatment is a medical treatment that activates the immune system. Prof. Ben-Eliyahu explains that surgery for the removal of the primary tumour is a mainstay in cancer treatment. But the risk of developing metastases after surgery is estimated at 10 per cent among breast cancer patients, at 20-40 per cent among colorectal cancer patients, and at 80 per cent among pancreatic cancer patients.

Source: Hindustan Times July 23, 2020 15:22 UTC